Safety Recall: Towa Pharmaceutical Loxoprofen Na Tape 50mg ‘TOWA’, Loxoprofen Na Tape 100mg ‘TOWA’, Diclofenac Sodium Tape 15mg ‘TOWA’, Diclofenac Sodium Tape 30mg ‘TOWA’ – Japan CAA

Published by Reclia Safety Desk | July 16, 2026

Recall Information Record

Case Number: 00000035558
Product: Loxoprofen Na Tape 50mg ‘TOWA’, Loxoprofen Na Tape 100mg ‘TOWA’, Diclofenac Sodium Tape 15mg ‘TOWA’, Diclofenac Sodium Tape 30mg ‘TOWA’
Brand: Towa Pharmaceutical
Hazards: Safety Risk
Source: Japan Consumer Affairs Agency (CAA)

WHAT HAPPENED

Towa Pharmaceutical has issued a voluntary recall for four of its topical analgesic tape products: Loxoprofen Na Tape 50mg ‘TOWA’, Loxoprofen Na Tape 100mg ‘TOWA’, Diclofenac Sodium Tape 15mg ‘TOWA’, and Diclofenac Sodium Tape 30mg ‘TOWA’. The recall was prompted by findings that the manufacturing and process management were conducted in a manner deviating from the approved product specifications, and that there were deficiencies in record-keeping.

This recall is significant because it involves widely used non-steroidal anti-inflammatory drug (NSAID) patches for pain relief. The deviations from approved manufacturing methods could potentially affect the quality, efficacy, or safety of the products. The Japan Consumer Affairs Agency (CAA) has published this notice under management number 00000035558, with reference information provided by the Pharmaceuticals and Medical Devices Agency (PMDA).

Consumers who have purchased these products should take the following steps:

• Check the product name on the package to confirm if it matches any of the four recalled items.
• Discontinue use of the affected product immediately.
• Contact Towa Pharmaceutical or the point of purchase for instructions on return and refund or replacement.
• Consult a healthcare professional if you have any concerns about your health or alternative treatments.

AFFECTED BATCHES & TARGET SPECIFICS

– **Target Model / Type:** N/A
– **JAN Barcode:** N/A
– **Affected Serial / Lot Numbers:** N/A
– **Total Units Affected:** N/A

ADDITIONAL REGULATORY NOTES

Recall initiated due to manufacturing and process management conducted in a manner inconsistent with the approved content, along with record-keeping deficiencies. The recall start date is July 14, 2026. Reference information is provided by PMDA. Management number: 00000035558.

❓ Frequently Asked Questions